Control of gastric acid secretion in health and disease

ML Schubert, DA Peura - Gastroenterology, 2008 - Elsevier
Recent milestones in the understanding of gastric acid secretion and treatment of acid-
peptic disorders include the (1) discovery of histamine H2-receptors and development of …

Gastric acid, calcium absorption, and their impact on bone health

S Kopic, JP Geibel - Physiological reviews, 2013 - journals.physiology.org
Calcium balance is essential for a multitude of physiological processes, ranging from cell
signaling to maintenance of bone health. Adequate intestinal absorption of calcium is a …

Randomised trial of acid inhibition by vonoprazan 10/20 mg once daily vs rabeprazole 10/20 mg twice daily in healthy Japanese volunteers (SAMURAI pH study)

T Takeuchi, T Furuta, Y Fujiwara… - Alimentary …, 2020 - Wiley Online Library
Background Vonoprazan (V), a potassium‐competitive acid blocker, has a more durable
acid‐inhibitory effect as compared with standard‐dose proton pump inhibitors (PPIs) but has …

Vonoprazan as a long-term maintenance treatment for erosive esophagitis: VISION, a 5-year, randomized, open-label study

N Uemura, Y Kinoshita, K Haruma, R Kushima… - Clinical …, 2024 - Elsevier
Background & Aims Acid secretion inhibitors are associated with hypergastrinemia, which
can lead to gastric mucosal changes. Potassium-competitive acid blockers, such as …

Pharmacological control of gastric acid secretion for the treatment of acid-related peptic disease: past, present, and future

T Aihara, E Nakamura, K Amagase, K Tomita… - Pharmacology & …, 2003 - Elsevier
Pharmacological agents, such as histamine H2 receptor antagonists and acid pump
inhibitors, are now the most frequently used treatment for such acid-related diseases as …

Gastric secretion

ML Schubert - Current opinion in gastroenterology, 2010 - journals.lww.com
We continue to make progress in our understanding of the regulation of gastric acid
secretion in health and disease. A better understanding of the pathways and mechanisms …

Pituitary adenylate cyclase-activating polypeptide (PACAP) in physiological and pathological processes within the gastrointestinal tract: a review

A Karpiesiuk, K Palus - International Journal of Molecular Sciences, 2021 - mdpi.com
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide widely
distributed in the central nervous system (CNS) and many peripheral organs, such as the …

The regulation of gastric acid secretion–clinical perspectives

HL Waldum, Ø Hauso, R Fossmark - Acta Physiologica, 2014 - Wiley Online Library
The purpose of this review, based upon 40 years of research, is to clear old controversies.
The gastric juice is a strong acid with active enzymes (pepsin and lipase); ideal for killing …

Gastric secretion

ML Schubert - Current opinion in gastroenterology, 2004 - journals.lww.com
An improved understanding of the pathways and mechanisms regulating gastric acid
secretion should lead to the development of novel therapies to prevent and treat acid-peptic …

The functional heterogeneity of PACAP: Stress, learning, and pathology

AK Rajbhandari, JR Barson, MR Gilmartin… - Neurobiology of learning …, 2023 - Elsevier
Pituitary adenylate cyclase-activating peptide (PACAP) is a highly conserved and widely
expressed neuropeptide that has emerged as a key regulator of multiple neural and …